Angiotensin Inhibition After Myocardial Infarction: Does Drug Class Matter?

BACKGROUND: Angiotensin converting enzyme-inhibitors (ACEI) and angiotensin-II-receptor blockers (ARB) are equally efficacious in reducing mortality after MI, although the latter are far more costly. Little is known about their relative use after MI in typical care settings, and about their relative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Winkelmayer, Wolfgang C, Fischer, Michael A, Schneeweiss, Sebastian, Levin, Raisa, Avorn, Jerry
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2006
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1924742/
https://ncbi.nlm.nih.gov/pubmed/17105523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2006.00590.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars